Prudential Financial’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-34,918
Closed -$4.02M 2571
2024
Q3
$4.02M Buy
34,918
+6,993
+25% +$793K 0.01% 1082
2024
Q2
$2.97M Buy
27,925
+10,214
+58% +$1.03M ﹤0.01% 1180
2024
Q1
$1.71M Sell
17,711
-7,557
-30% -$775K ﹤0.01% 1538
2023
Q4
$2.55M Buy
25,268
+2,633
+12% +$254K ﹤0.01% 1286
2023
Q3
$2.31M Buy
22,635
+4,172
+23% +$423K ﹤0.01% 1282
2023
Q2
$1.86M Buy
18,463
+5,272
+40% +$527K ﹤0.01% 1447
2023
Q1
$1.11M Sell
13,191
-2,818
-18% -$246K ﹤0.01% 1687
2022
Q4
$1.45M Buy
16,009
+5,449
+52% +$459K ﹤0.01% 1499
2022
Q3
$808K Buy
10,560
+1,126
+12% +$93.3K ﹤0.01% 1859
2022
Q2
$800K Sell
9,434
-866
-8% -$76K ﹤0.01% 1912
2022
Q1
$904K Buy
10,300
+1,500
+17% +$130K ﹤0.01% 1923
2021
Q4
$736K Sell
8,800
-196
-2% -$16.3K ﹤0.01% 2026
2021
Q3
$751K Sell
8,996
-491
-5% -$44.2K ﹤0.01% 1962
2021
Q2
$866K Buy
9,487
+387
+4% +$34.5K ﹤0.01% 1896
2021
Q1
$778K Buy
9,100
+1,422
+19% +$128K ﹤0.01% 1958
2020
Q4
$725K Buy
7,678
+1,815
+31% +$159K ﹤0.01% 1905
2020
Q3
$510K Sell
5,863
-609
-9% -$52.8K ﹤0.01% 1950
2020
Q2
$565K Buy
6,472
+3,208
+98% +$277K ﹤0.01% 1877
2020
Q1
$269K Buy
3,264
+691
+27% +$61.7K ﹤0.01% 2098
2019
Q4
$244K Buy
+2,573
New +$231K ﹤0.01% 2272

Other funds holding NVS

Prudential Financial's NVS Position: Q4 2024 in Review

Prudential Financial sold out of Novartis (NVS) in Q4 2024, closing a stake of 34,918 shares — an estimated $4.02M sold.

Prudential Financial first reported a position in NVS in Q4 2019 and held it in 20 quarters. The position peaked at $4.02M in Q3 2024. 1,340 funds tracked by Wall St. Rank hold NVS as of Q4 2024.

  • Prudential Financial reported no remaining Novartis position as of Q4 2024 after selling out during the quarter.
  • Prudential Financial sold 34,918 Novartis shares in Q4 2024, an estimated $4.02M.
  • Prudential Financial first reported a position in Novartis in Q4 2019 and held it in 20 quarters.
  • Prudential Financial's Novartis position peaked at $4.02M in Q3 2024.
  • 1,340 funds tracked by Wall St. Rank held Novartis as of Q4 2024.

Based on Prudential Financial's 13F filing for Q4 2024, filed 11 Feb 2025.